Researchers who presented their findings at the American Academy of Allergy, Asthma and Immunology’s annual meeting in February shed new light on the benefits of using immunotherapy to treat allergic rhinitis.
Explore this issue:
July 2015David I. Bernstein, MD, professor of medicine and co-director of the Allergy Fellowship Training Program in the division of immunology, allergy and rheumatology at the University of Cincinnati College of Medicine in Ohio, said his research demonstrated that sublingual immunotherapy (SLIT) tablet therapy can be used effectively in patients who may be allergic to Timothy grass and short ragweed and who also have additional allergic sensitivities.
“The presence of sensitization to other aeroallergens in addition to those pollen allergies being treated does not apparently affect treatment response,” he said. Some participants had conjunctivitis, while others did not.